News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
204,308 Results
Type
Article (10126)
Company Profile (72)
Press Release (194104)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (49234)
Career Advice (425)
Deals (10874)
Drug Delivery (15)
Drug Development (27641)
Employer Resources (23)
FDA (5912)
Job Trends (4041)
News (94462)
Policy (9235)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (726)
Accelerated approval (13)
Adcomms (6)
Allergies (33)
Alliances (12729)
ALS (58)
Alzheimer's disease (449)
Antibody-drug conjugate (ADC) (93)
Approvals (6154)
Artificial intelligence (147)
Autoimmune disease (42)
Automation (5)
Bankruptcy (77)
Best Places to Work (3555)
BIOSECURE Act (2)
Biosimilars (54)
Biotechnology (41)
Bladder cancer (92)
Brain cancer (39)
Breast cancer (284)
Cancer (2113)
Cardiovascular disease (191)
Career advice (326)
Career pathing (6)
CAR-T (60)
CDC (3)
Cell therapy (190)
Cervical cancer (13)
Clinical research (24484)
Collaboration (493)
Compensation (1109)
Complete response letters (9)
COVID-19 (703)
CRISPR (24)
C-suite (264)
Cystic fibrosis (47)
Data (2511)
Denatured (6)
Depression (27)
Diabetes (206)
Diagnostics (2179)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (62)
Drug pricing (19)
Drug shortages (2)
Duchenne muscular dystrophy (52)
Earnings (20759)
Editorial (16)
Employer branding (3)
Employer resources (23)
Events (32096)
Executive appointments (263)
FDA (7227)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (459)
Gene editing (60)
Generative AI (10)
Gene therapy (159)
GLP-1 (278)
Government (1616)
Grass and pollen (1)
Guidances (161)
Healthcare (6021)
HIV (22)
Huntington's disease (15)
IgA nephropathy (19)
Immunology and inflammation (55)
Immuno-oncology (14)
Indications (48)
Infectious disease (781)
Inflammatory bowel disease (51)
Influenza (36)
Intellectual property (58)
Interviews (50)
IPO (6430)
IRA (8)
Job creations (684)
Job search strategy (282)
JPM (17)
Kidney cancer (9)
Labor market (12)
Layoffs (118)
Leadership (13)
Legal (1483)
Liver cancer (51)
Longevity (5)
Lung cancer (331)
Lymphoma (158)
Machine learning (11)
Management (7)
Manufacturing (267)
MASH (52)
Medical device (4414)
Medtech (4429)
Mergers & acquisitions (4853)
Metabolic disorders (369)
Multiple sclerosis (39)
NASH (3)
Neurodegenerative disease (85)
Neuropsychiatric disorders (18)
Neuroscience (788)
NextGen: Class of 2026 (1799)
Non-profit (1739)
Now hiring (11)
Obesity (107)
Opinion (56)
Ovarian cancer (51)
Pain (57)
Pancreatic cancer (92)
Parkinson's disease (74)
Partnered (5)
Patents (113)
Patient recruitment (141)
Peanut (9)
People (14745)
Pharmaceutical (16)
Pharmacy benefit managers (4)
Phase 1 (6927)
Phase 2 (10706)
Phase 3 (8924)
Pipeline (1970)
Policy (37)
Postmarket research (886)
Preclinical (2821)
Press Release (16)
Prostate cancer (157)
Psychedelics (10)
Radiopharmaceuticals (302)
Rare diseases (254)
Real estate (1484)
Recruiting (8)
Regulatory (7830)
Reports (15)
Research institute (697)
Resumes & cover letters (104)
Rett syndrome (5)
RNA editing (4)
RSV (23)
Schizophrenia (46)
Series A (51)
Series B (47)
Service/supplier (4)
Sickle cell disease (26)
Special edition (3)
Spinal muscular atrophy (35)
Sponsored (11)
Startups (917)
State (1)
Stomach cancer (2)
Supply chain (26)
Tariffs (13)
The Weekly (11)
Vaccines (206)
Venture capital (31)
Weight loss (60)
Women's health (29)
Worklife (2)
Date
Today (33)
Last 7 days (215)
Last 30 days (726)
Last 365 days (10740)
2026 (1021)
2025 (10809)
2024 (12039)
2023 (13170)
2022 (16908)
2021 (18211)
2020 (16560)
2019 (14064)
2018 (10538)
2017 (9671)
2016 (8599)
2015 (10336)
2014 (7615)
2013 (6190)
2012 (6612)
2011 (7169)
2010 (6453)
Location
Africa (156)
Alabama (9)
Alaska (2)
Arizona (68)
Arkansas (1)
Asia (10384)
Australia (1941)
California (3703)
Canada (1020)
China (312)
Colorado (150)
Connecticut (193)
Delaware (158)
Europe (27354)
Florida (639)
Georgia (114)
Hawaii (1)
Idaho (17)
Illinois (302)
India (16)
Indiana (256)
Iowa (8)
Japan (163)
Kansas (42)
Kentucky (18)
Louisiana (9)
Maine (18)
Maryland (618)
Massachusetts (2637)
Michigan (72)
Minnesota (176)
Mississippi (1)
Missouri (63)
Montana (3)
Nebraska (8)
Nevada (30)
New Hampshire (15)
New Jersey (1129)
New Mexico (4)
New York (984)
North Carolina (1442)
North Dakota (5)
Northern California (1895)
Ohio (144)
Oklahoma (5)
Oregon (11)
Pennsylvania (794)
Puerto Rico (5)
Rhode Island (12)
South America (305)
South Carolina (55)
Southern California (1394)
Tennessee (26)
Texas (644)
United States (14652)
Utah (115)
Virginia (85)
Washington D.C. (45)
Washington State (344)
West Virginia (1)
Wisconsin (46)
204,308 Results for "c rad".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RAD Increases Ownership in Radiopharm Ventures to 87.5%
January 12, 2026
·
3 min read
Press Releases
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
January 29, 2026
·
1 min read
Press Releases
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 44th Annual Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Bio-Rad Reports Third-Quarter 2025 Financial Results
October 29, 2025
·
21 min read
Business
RaySearch and C-RAD sign collaboration agreement
RaySearch Laboratories AB and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
May 4, 2024
·
2 min read
Press Releases
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025
·
5 min read
Press Releases
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
November 18, 2025
·
4 min read
Press Releases
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
October 16, 2025
·
1 min read
Press Releases
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
November 13, 2025
·
3 min read
Press Releases
Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer
November 19, 2025
·
2 min read
1 of 20,431
Next
